Literature DB >> 30112630

Cytosolic Phospholipase A2 Facilitates Oligomeric Amyloid-β Peptide Association with Microglia via Regulation of Membrane-Cytoskeleton Connectivity.

Tao Teng1, Li Dong2, Devin M Ridgley1, Shivesh Ghura3, Matthew K Tobin3, Grace Y Sun4, Mary Jo LaDu3, James C Lee5.   

Abstract

Cytosolic phospholipase A2 (cPLA2) mediates oligomeric amyloid-β peptide (oAβ)-induced oxidative and inflammatory responses in glial cells. Increased activity of cPLA2 has been implicated in the neuropathology of Alzheimer's disease (AD), suggesting that cPLA2 regulation of oAβ-induced microglial activation may play a role in the AD pathology. We demonstrate that LPS, IFNγ, and oAβ increased phosphorylated cPLA2 (p-cPLA2) in immortalized mouse microglia (BV2). Aβ association with primary rat microglia and BV2 cells, possibly via membrane-binding and/or intracellular deposition, presumably indicative of microglia-mediated clearance of the peptide, was reduced by inhibition of cPLA2. However, cPLA2 inhibition did not affect the depletion of this associated Aβ when cells were washed and incubated in a fresh medium after oAβ treatment. Since the depletion was abrogated by NH4Cl, a lysosomal inhibitor, these results suggested that cPLA2 was not involved in the degradation of the associated Aβ. To further dissect the effects of cPLA2 on microglia cell membranes, atomic force microscopy (AFM) was used to determine endocytic activity. The force for membrane tether formation (Fmtf) is a measure of membrane-cytoskeleton connectivity and represents a mechanical barrier to endocytic vesicle formation. Inhibition of cPLA2 increased Fmtf in both unstimulated BV2 cells and cells stimulated with LPS + IFNγ. Thus, increasing p-cPLA2 would decrease Fmtf, thereby increasing endocytosis. These results suggest a role of cPLA2 activation in facilitating oAβ endocytosis by microglial cells through regulation of the membrane-cytoskeleton connectivity.

Entities:  

Keywords:  Alzheimer’s disease; Aβ clearance; Cytosolic phospholipase A2; Membrane-cytoskeleton connectivity; Microglia

Mesh:

Substances:

Year:  2018        PMID: 30112630      PMCID: PMC6461538          DOI: 10.1007/s12035-018-1304-5

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  65 in total

1.  Membrane tether formation from blebbing cells.

Authors:  J Dai; M P Sheetz
Journal:  Biophys J       Date:  1999-12       Impact factor: 4.033

Review 2.  Cell control by membrane-cytoskeleton adhesion.

Authors:  M P Sheetz
Journal:  Nat Rev Mol Cell Biol       Date:  2001-05       Impact factor: 94.444

Review 3.  How proteins move lipids and lipids move proteins.

Authors:  H Sprong; P van der Sluijs; G van Meer
Journal:  Nat Rev Mol Cell Biol       Date:  2001-07       Impact factor: 94.444

Review 4.  Microglial chemotaxis, activation, and phagocytosis of amyloid beta-peptide as linked phenomena in Alzheimer's disease.

Authors:  J Rogers; L F Lue
Journal:  Neurochem Int       Date:  2001 Nov-Dec       Impact factor: 3.921

5.  Microglial phagocytosis of fibrillar beta-amyloid through a beta1 integrin-dependent mechanism.

Authors:  Jessica Koenigsknecht; Gary Landreth
Journal:  J Neurosci       Date:  2004-11-03       Impact factor: 6.167

6.  Cytosolic phospholipase A2 is induced in reactive glia following different forms of neurodegeneration.

Authors:  D Stephenson; K Rash; B Smalstig; E Roberts; E Johnstone; J Sharp; J Panetta; S Little; R Kramer; J Clemens
Journal:  Glia       Date:  1999-08       Impact factor: 7.452

Review 7.  Phospholipase A2 in the central nervous system: implications for neurodegenerative diseases.

Authors:  Grace Y Sun; Jianfeng Xu; Michael D Jensen; Agnes Simonyi
Journal:  J Lipid Res       Date:  2003-12-01       Impact factor: 5.922

8.  Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability.

Authors:  Karie N Dahlgren; Arlene M Manelli; W Blaine Stine; Lorinda K Baker; Grant A Krafft; Mary Jo LaDu
Journal:  J Biol Chem       Date:  2002-06-10       Impact factor: 5.157

9.  Intracellular accumulation and resistance to degradation of the Alzheimer amyloid A4/beta protein.

Authors:  M F Knauer; B Soreghan; D Burdick; J Kosmoski; C G Glabe
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

Review 10.  Neuroinflammatory signaling upregulation in Alzheimer's disease.

Authors:  W J Lukiw; N G Bazan
Journal:  Neurochem Res       Date:  2000-10       Impact factor: 4.414

View more
  4 in total

1.  Cell-Matrix Interactions Regulate Functional Extracellular Vesicle Secretion from Mesenchymal Stromal Cells.

Authors:  Stephen Lenzini; Koushik Debnath; Jagdish C Joshi; Sing Wan Wong; Kriti Srivastava; Xue Geng; Ik Sung Cho; Angela Song; Raymond Bargi; James C Lee; Gary C H Mo; Dolly Mehta; Jae-Won Shin
Journal:  ACS Nano       Date:  2021-10-22       Impact factor: 18.027

2.  Effects of Docosahexaenoic Acid and Its Peroxidation Product on Amyloid-β Peptide-Stimulated Microglia.

Authors:  Xue Geng; Bo Yang; Runting Li; Tao Teng; Mary Jo Ladu; Grace Y Sun; C Michael Greenlief; James C Lee
Journal:  Mol Neurobiol       Date:  2019-11-01       Impact factor: 5.590

3.  Roles of microglial membranes in Alzheimer's disease.

Authors:  Jae-Won Shin; James C Lee
Journal:  Curr Top Membr       Date:  2020-09-11       Impact factor: 3.049

Review 4.  Dynamic Role of Phospholipases A2 in Health and Diseases in the Central Nervous System.

Authors:  Grace Y Sun; Xue Geng; Tao Teng; Bo Yang; Michael K Appenteng; C Michael Greenlief; James C Lee
Journal:  Cells       Date:  2021-10-30       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.